IN SILICO STUDY : HERMETIA ILLUCENS BASED ACUTE RESPIRATORY INFECTION TREATMENT

  • Sintia Intan Agsari Agsari IPB University
  • Imam Ali Alzaini Bychaqi Institut Pertanian Bogor
  • Bintang Aditia Tri Wibowo Institut Pertanian Bogor
Abstract views: 34 , PDF downloads: 36
Keywords: Acute respiratory infection, Hermetia illucens, in silico, Streptococcus pneumoniae

Abstract

The novel coronavirus is now referred to as severe and critical acute respiratory syndrome coronavirus-2 (SARS-CoV-2). There have been few studies about SARS-CoV-2 co-infection may significantly inhibit the immune system of host, increase antibacterial therapy intolerance, and be harmful to the prognosis of the disease. The highest co infection comes from Streptococcus pneumoniae. Bacterial co-infection in the setting of viral  pneumonia is known as major cause of mortality. Therefore, therapeutics such as antibiotics are needed to be able to kill and inhibit these bacteria. In this connection, the inaccurate use of antibiotics causes multi-drug resistant and worsens their immature immune systems. Hermetia illucens contains AMPs and various amino acids that synergistically have the potential to overcome this problem. Research on the use of crude maggot extract as a candidate for acute respiratory infection treatment products is still not available and has never been reported. This study aims to conduct in silico computerized tests related to the potential of maggot extract as antibacterial and anti-inflammatory properties, analyze its interaction with target proteins, bioavailability and ligand toxicity in maggot extract, and docking analysis of ligand-receptor. The results showed that the maggot extract had activity as peptidoglycan glycosyltransferase inhibitor, antibacterial, and anti-inflammatory. A binding affinity of the maggot AMPs ligands (defensin, diptericin, and attacin) to MurC receptor protein Streptococcus pneumoniae is also found. The antibacterial and anti-inflammatory abilities of bioactive maggots have the potential for used as a candidate treatment products for SARS-CoV-2 co-infection with Streptococcus pneumoniae as a biomedical innovation.

Downloads

Download data is not yet available.

References

Zhu, X. Ge, Y. Wu, T. Zhao, K. Chen, Y. Wu, B. Cui, L. 2020. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Research. 285: 198005

Yu, M. Li, Z. Chen, W. Rong, T. Wang, G. Wang, F. Ma, X. 2020. Evaluation of full-fat Hermetia illucens larvae meal as a fishmeal replacement for weanling piglets: effect on the growth performance, apparent nutrient digestibility, blood parameters, and gut morphology. Animal Feed Science and Technology. 40. 1-10.

Duployez, C. Guem, RL. Tinez, C. Lejeuna, AL. Robriquet, L. Six, S. Lorez, C. Wallet, F. 2020. Panton-Valentine leukocidin-secreting Staphylococus aureus pneumonia complicating COVID-19. Emerging Infectious Disease. 26 (8): 1939-1941.

Hapsari, MM. Keuter, HFM. Broek, VN. Hadi, U. Herawati, Y. Anggoro, DB. Sachro. 2016. Penurunan penggunaan antibiotik pada pasien anak penurunan penggunaan antibiotik pada pasien anak dengan demam. Jurnal Sari Pediatri. 8 (1): 16–24.

Uvel, H. Engström, Y. 2007. A multilayered defense against infection: combinatorial control of insect immune genes. Trends in Genetics. 23(7): 342–349.

Kusumaningtyas, E. 2018. Aplikasi peptida untuk meningkatkan kesehatan dan produktivitas ternak. Jurnal Wartazoa. 28 (2): 89-98.

Wardhana, AH. 2016. Black soldier fly (Hermetia illucens) sebagai sumber protein alternatif untuk pakan ternak. Jurnal Wartazoa. 26(2): 69-78.

Choi, WH, Jiang, M. 2014. Evaluation of antibacterial activity of hexanedioic acid isolated from Hermetia illucens larvae. Journal of Biomedicine. 12(3) :179- 189.

Filimonov, D.A., A.A. Lagunin, T.A. Gloriozova, A.V. Rudik, D.S. Druzhilovskii,

P.V. Pogodin, V.V. Poroikov. (2014). Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chemistry of Heterocyclic Compounds. 50(3): 444-457.

Moraes, GL. Gomes, GC. Sousa, PRM. Alves, CM. Thavendran. Kruger, HG. Maguire, GE. Lamichhane, G. Lameira, J. 2015. Structural and functional

Chambers, M.C., K.L. Lightfield, D.D. Schneider. (2012). How the fly balances its ability to combat different pathogens. PLoS Pathog. 8(12). e1002970

Darras, F.H., & Y.P. Pang. (2017). On the use of the experimentally determined enzyme inhibition constant as a measure of absolute binding affinity. Biochemical and Biophysical Research Communications. 489(4): 451-454.

Benet, L.Z, C.M. Hosey, O. Ursu, T.I. Oprea. (2016). BDDCS, the rule of 5 and drugabillity. Adv Drug Deliv Rev. 101: 89-98.

Loomis, TA. Hayes, AW. 1996. Loomis’s Essentials of Toxicology. USA: Academic Press, Inc. doi.org/10.1016/B978-0-12-455625-6.50018-0

PlumX Metrics

Published
2024-03-10
How to Cite
Agsari, S. I. A., Alzaini Bychaqi, I. A., & Tri Wibowo, B. A. (2024). IN SILICO STUDY : HERMETIA ILLUCENS BASED ACUTE RESPIRATORY INFECTION TREATMENT. JARES (Journal of Academic Research and Sciences), 9(1), 92-105. https://doi.org/10.35457/jares.v9i1.1363
Section
Articles